Feasibility and cost-effectiveness of treating multidrug-resistant tuberculosis: a cohort study in the Philippines (Q28469046)

multidrug-resistant tuberculosis

inferred from title

1 reference

Thelma E Tupasi

1

0 references

Rajesh Gupta

2

0 references

Ma Imelda D Quelapio

3

0 references

Ruth B Orillaza

4

0 references

Nona Rachel Mira

5

0 references

Nellie V Mangubat

6

0 references

Virgil Belen

7

0 references

Nida Arnisto

8

0 references

Lualhati Macalintal

9

0 references

Michael Arabit

10

0 references

Jaime Y Lagahid

11

0 references

Marcos Espinal

12

0 references

Katherine Floyd

Creative Commons Attribution 4.0 International

13

0 references

language of work or name

English

0 references

publication date

September 2006

0 references

published in

PLOS MEDICINE

0 references

volume

3

0 references

page(s)

e352

0 references

issue

9

0 references

copyright license

start time

12 September 2006

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1564168

Treatment and Outcome Analysis of 205 Patients with Multidrug-resistant Tuberculosis

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1564168

Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1564168

Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1564168

The world health report 2002 - reducing risks, promoting healthy life

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1564168

Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis.

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1564168

Programmes and principles in treatment of multidrug-resistant tuberculosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1564168

DOTS-Plus for multidrug-resistant tuberculosis in the Philippines: global assistance urgently needed

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1564168

Increasing transparency in partnerships for health--introducing the Green Light Committee

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1564168

Treatment experience of multidrug-resistant tuberculosis in Florida, 1994-1997.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1564168

Multidrug-resistant tuberculosis: long term follow-up of 40 non-HIV-infected patients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1564168

A cost-benefit analysis of BCG revaccination in the Czech Republic

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1564168

Cost-effectiveness of chemotherapy for sputum smear-positive pulmonary tuberculosis in Malawi, Mozambique and Tanzania

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1564168

The long-term dynamics of tuberculosis and other diseases with long serial intervals: implications of and for changing reproduction numbers

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1564168

Multidrug-resistant tuberculosis in Denmark 1993-1995.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1564168

The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1564168

Feasibility and cost-effectiveness of standardised second-line drug treatment for chronic tuberculosis patients: a national cohort study in Peru

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1564168

Treatment and follow-up of HIV-negative multidrug-resistant tuberculosis patients in an infectious diseases reference hospital, Buenos Aires, Argentina

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1564168

Self-administered, standardized regimens for multidrug-resistant tuberculosis in South Korea.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1564168

Frequency of recurrence among MDR-tB cases 'successfully' treated with standardised short-course chemotherapy

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1564168

The treatment of multidrug-resistant tuberculosis in Turkey

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1564168

Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1564168

Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1564168

Outcome of multi-drug-resistant tuberculosis in France: a nationwide case-control study.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1564168

Drug-resistant tuberculosis in the Philippines.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1564168

Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1564168

PUBLIC HEALTH: Responding to Market Failures in Tuberculosis Control

27 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16968123

12 December 2020

inferred from PubMed ID database lookup

Multidrug-resistant tuberculosis: long-term treatment outcome in the Netherlands

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16968123

12 December 2020

inferred from PubMed ID database lookup

Multidrug-resistant tuberculosis in patients without HIV infection

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16968123

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1371/JOURNAL.PMED.0030352

1 reference

4929017

4929017

1 reference

1 reference

1 reference